Should Pharma Site Metadata Play by the Same Rules as Paid Search Ads? This is the second entry in the series about “promotional peccadilloes” available on Convergence Point Media’s Insights blog – topics that often trigger a perceived conflict between good regulatory compliance and effective marketing, and our perspectives on best practices to address them. The […]
DTC Perspectives Announces 2017 Advertising Awards Finalists
The leading forum for direct-to-consumer (DTC) advertising thought leaders honors a dynamic group of pharmaceutical companies and brands at the much-anticipated DTC National Advertising Awards. The awards are part of the 17th Annual DTC National Conference to be held April 5-7 in Boston. Sponsored by Health Monitor Network, the 2017 Advertising Awards will showcase the […]
DTC in Perspective: Keytruda Enters the DTC Arena
Merck’s cancer drug Keytruda recently began its DTC campaign competing with Bristol Myers’ Opdivo. What is significant is that highly targeted drug categories continue to invest heavily in DTC. Keytruda is a biologic injection that has indications for non small cell lung cancer, advanced melanoma and head and neck cancer. The market is small by […]
DTC Perspectives Announces Top 25 DTC Marketers of the Year
DTC Perspectives, the leading forum for direct-to-consumer (DTC) advertising thought leaders names its 16th Annual list of the “Top 25 DTC Marketers of the Year.” This year’s class will be honored during a joint ceremony dinner recognizing the 2017 Top 25 DTC Marketers and Hall of Fame class on the evening of April 5 sponsored […]
DTC in Perspective: PhRMA Gets Bold
This week many drug CEOs met with President Trump to discuss pricing and innovation. In just two weeks Mr. Trump has sat down with a number of business leaders to push domestic investment in job creation. He pushed the drug makers to build factories here and get control of drug prices. In return Trump promised […]
DTC in Perspective: Did Obamacare Help or Hurt Americans?
Trying to be objective about Obamacare seems to be as difficult as with every other major policy issue these days. The newspaper headlines from the media are saying thousands of people will die if Obamacare is repealed. The Washington Post in a January 23 story cited estimates by medical professors who estimate the number at […]
DTC in Perspective: Repeal, Replace and DTC Growth
DTC will be much more important in the new health care era post Obamacare. This is not just for drug companies but for all health care goods and services. The Trumpcare plan will be shifting more decisions on health care to consumers based on free market competition. Americans will be given greater control over spending […]
DTC in Perspective: FDA Wants to See if Consumers Recognize Deceptive Ads
In what might be the most puzzling FDA DTC study proposed to date, the agency wants to see if consumers can recognize deceptive claims in DTC ads. In this study FDA wants to create mock ads with deceptive claims to see if consumers recognize those false claims and evaluate how that affects their perceptions of […]
These 7 Questions Can Mean the Difference Between Success Or Failure With Your Patient App
Pharmaceutical patient apps are a hot topic among brand teams these days. They hold great promise for a brand across the patient journey, from supporting a dialog with physicians to setting treatment expectations to supporting disease or lifestyle management to providing support to maximize adherence. Yet, for all its promise, many brand teams have been […]
Engagement to Outcomes
Over the past 25 years, PatientPoint has established themselves as a leader of patient and physician engagement solutions at the point of care. The company closed out 2016 on a high, with the launch of a new mobile app, PatientPoint 360, as well as the acquisition of MedCenterDisplay. This week, they kept the momentum rolling with […]